Curcumin modulated gut microbiota and alleviated renal fibrosis in 5/6 nephrectomy-induced chronic kidney disease rats.

Increasing evidence suggests that dysbiosis of gut microbiota exacerbates chronic kidney disease (CKD) progression. Curcumin (CUR) has been reported to alleviate renal fibrosis in animal models of CKD. However, the relationship between CUR and gut microbiome in CKD remains unclear. This study aims t...

Full description

Saved in:
Bibliographic Details
Main Authors: Cheng Li, Xulong Chen, Jingchun Yao, Weiwei Zha, Meiren Li, Jiangwen Shen, Hongli Jiang, PuXun Tian
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0314029
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841533139097223168
author Cheng Li
Xulong Chen
Jingchun Yao
Weiwei Zha
Meiren Li
Jiangwen Shen
Hongli Jiang
PuXun Tian
author_facet Cheng Li
Xulong Chen
Jingchun Yao
Weiwei Zha
Meiren Li
Jiangwen Shen
Hongli Jiang
PuXun Tian
author_sort Cheng Li
collection DOAJ
description Increasing evidence suggests that dysbiosis of gut microbiota exacerbates chronic kidney disease (CKD) progression. Curcumin (CUR) has been reported to alleviate renal fibrosis in animal models of CKD. However, the relationship between CUR and gut microbiome in CKD remains unclear. This study aims to investigate the potential anti-renal fibrosis effects of CUR from the gut microbiota perspective. A 5/6 nephrectomy (5/6Nx) rat model was used to explore the therapeutic effect of CUR on renal fibrosis. Tight junction protein expression levels were measured to assess intestinal barrier function. 16S rRNA sequencing was employed to evaluate changes in gut microbiota composition, and metabolomics was utilized to detect alterations in plasma metabolites. The administration of CUR significantly ameliorated renal fibrosis and inhibited inflammation in 5/6Nx rats. Additionally, CUR markedly improved the expression of tight junction proteins and local colon inflammation. CUR also positively reconstructed gut microbiota, significantly increasing the abundance of beneficial bacteria, such as Lachnospiraceae_NK4A136_group, Eubacterium_siraeum_group, and Muribaculaceae was significantly increased. Metabolomics revealed that CUR reduced uremic retention solutes and elevated Vitamin D and short-chain fatty acids (SCFAs). Spearman correlation analysis indicated that gut genera enriched by CUR were positively correlated with Vitamin D and SCFA and negatively correlated with chronic renal injury biomarkers. Mechanistically, we found inhibition of the LPS/TLR4/NF-κB and TGF-β1/Smads pathway in CUR-treated rats. Our study indicates that CUR has the potential to modulate gut microbiota composition, and that this modulation may contribute to the anti-fibrosis effects of CUR.
format Article
id doaj-art-0d7ed766aea0455b9c6fdc776f7ea8de
institution Kabale University
issn 1932-6203
language English
publishDate 2025-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-0d7ed766aea0455b9c6fdc776f7ea8de2025-01-17T05:31:26ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01201e031402910.1371/journal.pone.0314029Curcumin modulated gut microbiota and alleviated renal fibrosis in 5/6 nephrectomy-induced chronic kidney disease rats.Cheng LiXulong ChenJingchun YaoWeiwei ZhaMeiren LiJiangwen ShenHongli JiangPuXun TianIncreasing evidence suggests that dysbiosis of gut microbiota exacerbates chronic kidney disease (CKD) progression. Curcumin (CUR) has been reported to alleviate renal fibrosis in animal models of CKD. However, the relationship between CUR and gut microbiome in CKD remains unclear. This study aims to investigate the potential anti-renal fibrosis effects of CUR from the gut microbiota perspective. A 5/6 nephrectomy (5/6Nx) rat model was used to explore the therapeutic effect of CUR on renal fibrosis. Tight junction protein expression levels were measured to assess intestinal barrier function. 16S rRNA sequencing was employed to evaluate changes in gut microbiota composition, and metabolomics was utilized to detect alterations in plasma metabolites. The administration of CUR significantly ameliorated renal fibrosis and inhibited inflammation in 5/6Nx rats. Additionally, CUR markedly improved the expression of tight junction proteins and local colon inflammation. CUR also positively reconstructed gut microbiota, significantly increasing the abundance of beneficial bacteria, such as Lachnospiraceae_NK4A136_group, Eubacterium_siraeum_group, and Muribaculaceae was significantly increased. Metabolomics revealed that CUR reduced uremic retention solutes and elevated Vitamin D and short-chain fatty acids (SCFAs). Spearman correlation analysis indicated that gut genera enriched by CUR were positively correlated with Vitamin D and SCFA and negatively correlated with chronic renal injury biomarkers. Mechanistically, we found inhibition of the LPS/TLR4/NF-κB and TGF-β1/Smads pathway in CUR-treated rats. Our study indicates that CUR has the potential to modulate gut microbiota composition, and that this modulation may contribute to the anti-fibrosis effects of CUR.https://doi.org/10.1371/journal.pone.0314029
spellingShingle Cheng Li
Xulong Chen
Jingchun Yao
Weiwei Zha
Meiren Li
Jiangwen Shen
Hongli Jiang
PuXun Tian
Curcumin modulated gut microbiota and alleviated renal fibrosis in 5/6 nephrectomy-induced chronic kidney disease rats.
PLoS ONE
title Curcumin modulated gut microbiota and alleviated renal fibrosis in 5/6 nephrectomy-induced chronic kidney disease rats.
title_full Curcumin modulated gut microbiota and alleviated renal fibrosis in 5/6 nephrectomy-induced chronic kidney disease rats.
title_fullStr Curcumin modulated gut microbiota and alleviated renal fibrosis in 5/6 nephrectomy-induced chronic kidney disease rats.
title_full_unstemmed Curcumin modulated gut microbiota and alleviated renal fibrosis in 5/6 nephrectomy-induced chronic kidney disease rats.
title_short Curcumin modulated gut microbiota and alleviated renal fibrosis in 5/6 nephrectomy-induced chronic kidney disease rats.
title_sort curcumin modulated gut microbiota and alleviated renal fibrosis in 5 6 nephrectomy induced chronic kidney disease rats
url https://doi.org/10.1371/journal.pone.0314029
work_keys_str_mv AT chengli curcuminmodulatedgutmicrobiotaandalleviatedrenalfibrosisin56nephrectomyinducedchronickidneydiseaserats
AT xulongchen curcuminmodulatedgutmicrobiotaandalleviatedrenalfibrosisin56nephrectomyinducedchronickidneydiseaserats
AT jingchunyao curcuminmodulatedgutmicrobiotaandalleviatedrenalfibrosisin56nephrectomyinducedchronickidneydiseaserats
AT weiweizha curcuminmodulatedgutmicrobiotaandalleviatedrenalfibrosisin56nephrectomyinducedchronickidneydiseaserats
AT meirenli curcuminmodulatedgutmicrobiotaandalleviatedrenalfibrosisin56nephrectomyinducedchronickidneydiseaserats
AT jiangwenshen curcuminmodulatedgutmicrobiotaandalleviatedrenalfibrosisin56nephrectomyinducedchronickidneydiseaserats
AT honglijiang curcuminmodulatedgutmicrobiotaandalleviatedrenalfibrosisin56nephrectomyinducedchronickidneydiseaserats
AT puxuntian curcuminmodulatedgutmicrobiotaandalleviatedrenalfibrosisin56nephrectomyinducedchronickidneydiseaserats